- 专利标题: Pathway analysis for identification of diagnostic tests
-
申请号: US14320214申请日: 2014-06-30
-
公开(公告)号: US11011273B2公开(公告)日: 2021-05-18
- 发明人: Stephen Charles Benz , Shahrooz Rabizadeh , Christopher Szeto , Paul Weingarten , Chunlin Tao
- 申请人: Nantomics, LLC
- 申请人地址: US CA Culver City
- 专利权人: Nantomics, LLC
- 当前专利权人: Nantomics, LLC
- 当前专利权人地址: US CA Culver City
- 代理机构: Umberg Zipser LLP
- 代理商 Martin Fessenmaier
- 主分类号: G16H50/20
- IPC分类号: G16H50/20 ; C07D403/14 ; C07D403/12 ; A61P35/00 ; A61K31/506 ; C07D401/14 ; C07D417/14 ; C07D413/14
摘要:
The present inventive subject matter provides apparatus, systems, and methods in which a diagnostic test is identified, where the diagnostic test is for determining whether a particular treatment is effective for a particular patient based on one or more characteristics of a patient's cells. When a treatment is developed with the potential to treat one or more diseases, the drug can have different effects on different cell lines related to the diseases. A machine learning system is programmed to infer a measurable cell characteristic, out of many different measurable cell characteristics, that has a desirable correlation with the sensitivity data of different cell lines to a treatment. The machine learning system is programmed to then determine, based on the correlation, a threshold level of the cell characteristic the patient should exhibit in order to recommend administering the treatment.
公开/授权文献
- US20150006445A1 PATHWAY ANALYSIS FOR IDENTIFICATION OF DIAGNOSTIC TESTS 公开/授权日:2015-01-01
信息查询